Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadopiclenol for Contrast Enhanced MRI in Prostate Cancer
NCT06226129Phase 4Suspended
- Sponsor
- Columbia University
- Start
- Feb 2024
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadopiclenol in prostate cancer (PCa), sponsored by Columbia University. Started Feb 2024; status: suspended.
02
Drugs
gadopiclenol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06226129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06226129.